<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00387101</url>
  </required_header>
  <id_info>
    <org_study_id>RS03-2004</org_study_id>
    <nct_id>NCT00387101</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety Study in the Treatment of Chronic Diabetic Foot Ulcers</brief_title>
  <official_title>Pivotal Study to Evaluate the Efficacy and Safety of Dermal-Living Skin Replacement (Dermal-LSR) in the Treatment of Chronic Diabetic Foot Ulcers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ApoPharma</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ApoPharma</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the safety and efficacy of Dermal-LSR plus Standard
      of Care (SOC) for the treatment of diabetic foot ulcers (DFU)in comparison to the treatment
      to SOC alone.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is a pivotal, prospective, randomized, controlled, open-label, multi-center study
      that will evaluate the effectiveness and safety of topically applied Dermal-LSR in chronic
      DFUs.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Low recruitment rate
  </why_stopped>
  <start_date>February 2006</start_date>
  <completion_date type="Actual">April 2008</completion_date>
  <primary_completion_date type="Actual">September 2007</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To determine the efficacy and safety of Dermal-LSR plus Standard of Care (SOC) for the treatment of chronic diabetic foot ulcers in comparison to treatment with SOC alone.</measure>
  </primary_outcome>
  <enrollment type="Anticipated">288</enrollment>
  <condition>Diabetic Foot Ulcer</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dermal - Living Skin Replacement (Dermal - LSR)</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Has signed a written informed consent prior to the first study intervention

          -  Is at least 18 and &lt;85 years of age

          -  Has one or more diabetic foot ulcers on the target limb, with only one marked for the
             study (target ulcer). It must have the following characteristics:Plantar; Grade 2 per
             Curative Health Services Classification; Non-infected; Neuropathic; Non-malignant; At
             least 1.0-25cm^2 post-debridement; Present for at least 6 weeks

          -  Has Type I or II Diabetes Mellitus with an HBA1c between 6-10%

          -  Has a maximum fasting blood glucose level of 13.8 mmol/L

          -  An ankle-brachial systolic pressure index between 0.7 and 1.3

          -  If female and of childbearing potential has a negative serum pregnancy test and is
             neither breastfeeding or intending to become pregnant during the study

          -  Able and willing to attend the scheduled visits and comply with study procedures.

        Exclusion Criteria:

          -  Known or suspected disease of the immune system

          -  Active or untreated malignancy or active, uncontrolled connective tissue disease

          -  Treatment with immunosuppressive or chemotherapeutic agents, radiotherapy or systemic
             corticosteroids less than 30 days before enrollment

          -  Presence of necrosis, purulence or sinus tracts that cannot be removed by debridement

          -  Has undergone revascularization procedure aimed at increasing blood flow in the
             treatment target limb &lt; 4 weeks prior to enrollment

          -  Active febrile illness

          -  AST, ALT, ALP &gt;3x the normal upper limit

          -  Serum Creatinine &gt;2x the normal upper limit

          -  Osteomyelitis

          -  Active Charcot

          -  Use of any topical treatments other than SOC (standard of care)at the time of
             enrollment

          -  Enrollment in any investigational clinical trial within 30 days of the screening visit

          -  Known or suspected hypersensitivity to any study product components

          -  Recent or current history of alcohol or drug abuse

          -  Any condition, which in the opinion of the Investigator, would interfere with the
             evaluation of the study product or poses a health risk to the subject

          -  All site personnel directly affiliated with this study and their immediate families
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>84 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jason R Hanft, DPM, FAC FAS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Doctors Research Network, 7000 SW 62nd Avenue, Suite 310, South Miami, FL 33143</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hau Pham, DPM</last_name>
    <role>Principal Investigator</role>
    <affiliation>Foot Care Vascular and Endovascular Specialists of Boston Medical Center, 732 Harrison Ave., 2nd Floor, Boston, MA 02118</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rodney Stuck, DPM</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hines VA Hospital, 5th and Roosevelt Rd., Building 200, 5th Floor, Room 501, Hines, IL 60141</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vickie Driver, DPM</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Center for Lower Limb Preservation, 8816 Dempster Street, Niles, Il 60714</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Zevi Isseroff, DPM</last_name>
    <role>Principal Investigator</role>
    <affiliation>North Shore Diabetic and Endocrine Associates, 3003 New Hyde Park Road Suite 201, New Hyde Park, NY, 11042</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lowell Weil, Jr., DPM, MBA, FAC FAS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Weil Foot and Ankle Institute, 1455 Golf Rd., Suite 110, Golf-River Professional Building, Des Plaines, IL 60016</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michal Drews</last_name>
    <role>Principal Investigator</role>
    <affiliation>SPSK nr 2 im. H. Święcickiego AM Oddział Kliniczny Chirurgii Ogólnej Gastroenterologicznej i Endokrynologicznej ul. Przybyszewskiego 49</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Henryk Komon</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centrum Medyczno-Diagnostyczne Sp. z o.o. ul. Piłsudskiego 49 08-110 Siedlce Poland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Krystyna Pilarska</last_name>
    <role>Principal Investigator</role>
    <affiliation>SPWSZ w Szczecinie Klinika Endokrynologii, NadciśnieniaTętniczego i Chorób Przemiany Materii PAM ul. Arkońska 4 71-455 Szczecin</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Malgorzata Wilczynska</last_name>
    <role>Principal Investigator</role>
    <affiliation>NZOZ Centrum Opieki Diabetologiczno-Endokrynologicznej ul. Karola Miarki 6 50-306 Wrocław Poland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Joseph Cavorsi, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Center for Advanced Wound Care 640 Walnut St., Suite 302 Reading, PA 19601</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Roslyn R Isseroff, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Veterans Affairs Northern Health Care System</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Georgeanne Botek, DPM</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Learner Research Centre, Department of Orthopaedic Surgery. The Cleveland Clinic Foundation, 9500 Euclid Ave. A40, Cleveland, OH 44195,</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Adam Landsman, DPM, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Joslin-Beth Israel Deaconess Foot Center, Division of Podiatry, 185 Pilgrim Road, Boston, MA 02215</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jodi Walters, DPM</last_name>
    <role>Principal Investigator</role>
    <affiliation>Southern Arizona Veterans Administration Health Care System, 3601 S. 6th Avenue (2-112), Tucson, AZ 85723</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Martin Taubman, DPM</last_name>
    <role>Principal Investigator</role>
    <affiliation>San Diego Research Center 4452 Park Boulevard Suite 210, San Diego, CA 92116</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Southern Arizona Veterans Administration Health Care System, 3601 S. 6th Avenue (2-112)</name>
      <address>
        <city>Tuscon</city>
        <state>Arizona</state>
        <zip>85723</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Veterans Affairs Northern Health Care System, Sacramento VA Medical Center at Mather</name>
      <address>
        <city>Mather</city>
        <state>California</state>
        <zip>95655</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>San Diego Research Center 4452 Park Boulevard Suite 210, San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92116</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Doctors Research Network</name>
      <address>
        <city>South Miami</city>
        <state>Florida</state>
        <zip>33143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Weil Foot and Ankle Institute</name>
      <address>
        <city>Des Plaines</city>
        <state>Illinois</state>
        <zip>60016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hines VA Hospital</name>
      <address>
        <city>Hines</city>
        <state>Illinois</state>
        <zip>60141</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Center for Lower Limb Preservation</name>
      <address>
        <city>Niles</city>
        <state>Illinois</state>
        <zip>60714</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Foot Care Vascular and Endovascular Specialists of Boston Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02118</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Joslin-Beth Israel Deaconess Foot Center, Division of Podiatry, 185 Pilgrim Road</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Shore Diabetic and Endocrine Associates</name>
      <address>
        <city>New Hyde Park</city>
        <state>New York</state>
        <zip>11042</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Learner Research Centre, Department of Orthopaedic Surgery. The Cleveland Clinic Foundation, 9500 Euclid Ave. A40</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Center for Advanced Wound Care</name>
      <address>
        <city>Reading</city>
        <state>Pennsylvania</state>
        <zip>19601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 10, 2006</study_first_submitted>
  <study_first_submitted_qc>October 10, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 12, 2006</study_first_posted>
  <last_update_submitted>April 30, 2008</last_update_submitted>
  <last_update_submitted_qc>April 30, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 2, 2008</last_update_posted>
  <keyword>Diabetic Foot Ulcer</keyword>
  <keyword>Diabetes Mellitus</keyword>
  <keyword>Debridement</keyword>
  <keyword>Dermal-LSR</keyword>
  <keyword>Standard of Care</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Diabetic Foot</mesh_term>
    <mesh_term>Foot Ulcer</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

